Ignite Creation Date:
2025-12-25 @ 2:37 AM
Ignite Modification Date:
2026-03-04 @ 10:28 AM
Study NCT ID:
NCT01934634
Status:
UNKNOWN
Last Update Posted:
2015-11-10
First Post:
2013-08-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Trial of LCL161 and Gemcitabine Plus Nab-Paclitaxel in Metastatic Pancreatic Cancer
Sponsor:
US Oncology Research
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03
Start Date Type:
None
Primary Completion Date:
2016-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2013-08-29
First Submit QC Date:
None
Study First Post Date:
2013-09-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-11-07
Last Update Post Date:
2015-11-10
Last Update Post Date Type:
ESTIMATED